Scan to Download
One power score. Smarter investment decisions
Acurx Pharmaceuticals Inc
ACXP4.100USD
-0.240-5.53%
收盤 09/19, 16:00（美東）報價延遲15分鐘
USD0.000盤後交易 (美東)
301.42K總市值
虧損本益比TTM
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
營業費用
-44.94%2.27M
-50.91%2.15M
-45.61%2.78M
-9.42%2.82M
19.64%4.12M
50.81%4.38M
56.86%5.11M
-12.05%3.11M
31.47%3.45M
8.72%2.90M
24.11%3.26M
-23.71%3.54M
-35.62%2.62M
81.11%2.67M
140.35%2.63M
253.14%4.64M
345.67%4.07M
15.26%1.47M
--1.09M
--1.31M
--913.36K
--1.28M
研發費用
-71.29%524.21K
-61.49%598.80K
-57.53%825.06K
-11.18%1.20M
5.14%1.83M
53.12%1.56M
35.60%1.94M
-15.21%1.35M
90.46%1.74M
24.02%1.02M
100.03%1.43M
41.18%1.59M
858.93%911.69K
790.99%818.89K
56.54%716.22K
70.76%1.13M
-76.28%95.07K
-86.58%91.91K
--457.53K
--659.98K
--400.74K
--684.73K
折舊攤銷及損耗
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
營業利潤
44.94%-2.27M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
35.62%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-345.67%-4.07M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
淨非營業利息收入（費用）
利息收入
--23.40K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
特殊收入（費用）
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--66.50K
--0.00
----
--0.00
--0.00
----
稅前利潤
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
除稅後利潤
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
持續經營利潤
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
歸属于母公司的淨利潤
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
歸屬普通股東的淨利潤
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
基本每股收益
-14390.81%-37.74
-658.08%-2.15
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
稀釋每股收益
-14390.81%-37.74
-658.08%-2.15
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
審計意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
